Garg Pawan K, Khera Pushpinder S, Saxena Suvinay, Sureka Binit, Garg M K, Nag Vijaya Lakshmi, Purohit Abhishek, Dutt Naveen, Tiwari Sarbesh, Yadav Taruna, Singh Surjit, Misra Sanjeev
Department of Diagnostic and Interventional Radiology, All India Institute of Medical Sciences, Jodhpur, India.
Department of General Medicine, All India Institute of Medical Sciences, Jodhpur, India.
Turk Thorac J. 2021 Mar;22(2):130-136. doi: 10.5152/TurkThoracJ.2021.20239. Epub 2021 Mar 1.
This study aimed to use chest-X-ray (CXR)-based scores along with total leukocyte count (TLC) and neutrophil-to-lymphocyte ratio (NLR) in the prediction of coronavirus disease 2019 (COVID-19) in patients presenting with clinical features of severe acute respiratory illness (SARI).
This is a retrospective study involving all patients who presented with clinical features of SARI and who had undergone bedside chest X-ray (CXR), hemograms with TLC, NLR, and reverse transcriptase-polymerase chain reaction (RT-PCR) at our institute from May 1 to June 30, 2020.
Of 204 patients, 115 tested RT-PCR-positive and 89 tested negative. The patients who presented with SARI, using CXR-based score of 4 or more, TLC of less than 8,700 cells/μL, and NLR of <7 had a statistically significant area under the curve (p<0.001) for diagnosing COVID-19. The sensitivity and specificity of the CXR score was 80.8% and 73.0%, of TLC was 70.1% and 74.7%, and of NLR was 70.1% and 59.0%, respectively, in diagnosing COVID-19 alone. The specificity further increased to 90.4% when we used the CXR score with NLR and to 92.8% when we used the CXR score with TLC. The post-test odds ("rule in" disease) of a positive test for having the disease were 3, 2.77, and 1.71 times with the use of either CXR score, TLC, or NLR criteria, respectively; whereas, combined use of CXR score and NLR increased the post-test odds by 5.53 times, and combination of CXR score with TLC increased the post-test odds by 7.5 times.
CXR score with TLC and NLR can predict COVID-19 infection among those who presented with features of SARI. This may help in the early isolation of the patient until the RT-PCR report becomes available.
本研究旨在利用基于胸部X线(CXR)的评分以及全白细胞计数(TLC)和中性粒细胞与淋巴细胞比值(NLR)来预测出现严重急性呼吸疾病(SARI)临床特征的患者的2019冠状病毒病(COVID-19)。
这是一项回顾性研究,纳入了2020年5月1日至6月30日期间在我院出现SARI临床特征并接受了床边胸部X线(CXR)、全血细胞计数(包括TLC、NLR)以及逆转录聚合酶链反应(RT-PCR)检测的所有患者。
204例患者中,115例RT-PCR检测呈阳性,89例检测呈阴性。出现SARI且基于CXR的评分为4分或更高、TLC低于8700个细胞/μL以及NLR<7的患者,在诊断COVID-19时曲线下面积具有统计学意义(p<0.001)。单独诊断COVID-19时,CXR评分的敏感性和特异性分别为80.8%和73.0%,TLC的敏感性和特异性分别为70.1%和74.7%,NLR的敏感性和特异性分别为70.1%和59.0%。当将CXR评分与NLR联合使用时,特异性进一步提高到90.4%,当将CXR评分与TLC联合使用时,特异性提高到92.8%。使用CXR评分、TLC或NLR标准进行疾病检测呈阳性时的检测后概率(“确诊”疾病)分别为3倍、2.77倍和1.71倍;而将CXR评分与NLR联合使用使检测后概率提高了5.53倍,将CXR评分与TLC联合使用使检测后概率提高了7.5倍。
CXR评分与TLC和NLR相结合可预测出现SARI特征的患者中的COVID-19感染情况。这可能有助于在RT-PCR报告出来之前对患者进行早期隔离。